Workflow
华东数控(002248) - 2023 Q1 - 季度财报
WHHDWHHD(SZ:002248)2023-04-28 16:00

Financial Performance - The company's operating revenue for Q1 2023 was ¥70,118,725.26, representing a 16.21% increase compared to ¥60,338,203.65 in the same period last year[3] - Net profit attributable to shareholders was ¥4,752,436.05, up 16.00% from ¥4,097,049.65 year-on-year[3] - The net profit after deducting non-recurring gains and losses increased by 36.11% to ¥3,764,465.92 from ¥2,765,811.12 in the previous year[3] - Basic and diluted earnings per share both doubled to ¥0.02 from ¥0.01 year-on-year[3] - Operating profit for the current period was ¥4,553,614.14, up from ¥4,006,920.87, reflecting a growth of 13.7%[17] - The company’s total profit for the current period was ¥4,684,092.38, an increase from ¥4,019,397.15 in the previous period, showing overall growth[17] Cash Flow - The net cash flow from operating activities improved significantly to ¥8,633,841.76, a 271.32% increase from a negative cash flow of -¥5,039,453.40 in the same period last year[3] - Cash and cash equivalents at the end of the period were ¥28,063,307.43, up from ¥17,970,637.73 in the previous period[21] - The company experienced a net cash outflow from investing activities of ¥10,689,308.29, compared to a smaller outflow of ¥137,850.81 in the previous period[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥558,071,291.47, a slight decrease of 0.48% from ¥560,740,396.04 at the end of the previous year[3] - Total current assets decreased from 440,493,573.77 CNY at the beginning of the year to 435,301,730.89 CNY at the end of the period, a decrease of approximately 0.43%[13] - Total liabilities decreased from 484,417,930.60 CNY to 476,737,488.40 CNY, a reduction of approximately 1.4%[15] - Total assets decreased from 560,740,396.04 CNY to 558,071,291.47 CNY, a decline of about 0.5%[15] Shareholder Information - Total number of common shareholders at the end of the reporting period is 65,524[9] - The largest shareholder, Weihai Weigao International Medical Investment Holding Co., Ltd., holds 17.50% of shares, totaling 53,825,800 shares[9] - Shareholders' equity attributable to the parent company increased by 6.62% to ¥81,826,057.33 from ¥76,746,376.03 at the end of the previous year[3] - The total equity attributable to shareholders of the parent company increased from 76,746,376.03 CNY to 81,826,057.33 CNY, an increase of approximately 6.7%[15] Operating Costs and Expenses - The company reported a decrease in total operating costs to ¥65,775,688.44 from ¥56,970,550.81, resulting in improved profitability[17] - Research and development expenses increased to ¥2,289,609.40 from ¥2,080,598.39, indicating a focus on innovation[17] - The company experienced a 142.32% increase in taxes and surcharges, amounting to ¥300,269.34 due to increased turnover taxes[6] Other Financial Metrics - The company reported a significant increase in other operating income, which rose by 945.81% to ¥130,478.24 compared to ¥12,476.28 in the previous year[6] - The company reported a 371.14% increase in receivables financing, reaching ¥11,414,601.47 compared to ¥2,422,782.93 in the previous year[6] - The company's retained earnings showed a slight improvement, moving from -1,037,947,558.95 CNY to -1,033,195,122.90 CNY[15]